Safety of ciprofloxacin in children: Worldwide clinical experience based on compassionate use. Emphasis on joint evaluation
- 1 July 1991
- journal article
- review article
- Published by Springer Nature in Infection
- Vol. 19 (4), 289-296
- https://doi.org/10.1007/bf01644970
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Use of quinolones in pediatricsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Ciprofloxacin in the treatment of Pseudomonas infection in children with cystic fibrosisDiagnostic Microbiology and Infectious Disease, 1990
- Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrationsArchives of Toxicology, 1990
- Acute epididymo-orchitis caused by Pseudomonas aeruginosa and treated with ciprofloxacinJournal of Infection, 1989
- Antipseudomonal therapy in cystic fibrosis: Aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Cystic Flbrosis and Drug-induced ArthropathyRheumatology, 1989
- Clinical Pharmacokinetics in Infants and Children A ReappraisalClinical Pharmacokinetics, 1989
- Arthropathy in a patient with cystic fibrosis taking ciprofloxacin.BMJ, 1987
- CIPROFLOXACIN FOR CHOLANGITIS AFTER HEPATIC PORTOENTEROSTOMYThe Lancet, 1987
- Arthropathy induced by antibacterial fused N-alkyl-4-pyridone-3-carboxylic acidsToxicology Letters, 1977